Cybin Inc
CYBN7.500USD
-0.060-0.79%
交易中 （美東）報價延遲15分鐘
162.08M總市值
虧損本益比TTM
關於 Cybin Inc 公司
Cybin Inc. 是一家總部位於加拿大的臨牀階段生物製藥公司。該公司開發基於迷幻藥的療法，以滿足患有精神疾病的人對治療方案的未滿足需求。其 N,N-二甲基色胺 (DMT) 和 dDMT 項目創建了對這些迷幻分子進行系統研究的數據集。該公司正在開發 CYB003（一種用於治療重度抑鬱症的專有氘代裸蓋菇素類似物）和 CYB004（一種用於治療廣泛性焦慮症的專有氘代 dDMT 分子），並擁有一系列基於迷幻藥的在研化合物。CYB003 進入第三階段，CYB004 進入第二階段。它在迷幻藥開發領域擁有知識產權組合，已獲得 30 多項專利，還有 160 項專利正在申請中。該公司在加拿大、美國、英國、荷蘭和愛爾蘭開展業務。
公司簡介
公司代碼CYBN
公司名稱Cybin Inc
上市日期Jan 05, 2018
CEOMr. Douglas (Doug) Drysdale
員工數量50
證券類型Ordinary Share
年結日Jan 05
公司地址100 King Street West
城市TORONTO
上市交易所Aequitas NEO-L
國家Canada
郵編M5X 1C9
電話19087648385
網址https://www.cybin.com
公司代碼CYBN
上市日期Jan 05, 2018
CEOMr. Douglas (Doug) Drysdale
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. George Tziras
Mr. George Tziras
Director, Chief Business Officer
Director, Chief Business Officer
1.29M
--
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President
Executive Chairman of the Board, President
311.12K
-97.37%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
287.70K
+0.24%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
Mr. Greg Cavers
Mr. Greg Cavers
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Lawson
Mr. Mark Lawson
Independent Director
Independent Director
--
--
Mr. Douglas (Doug) Drysdale
Mr. Douglas (Doug) Drysdale
Chief Executive Officer
Chief Executive Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. George Tziras
Mr. George Tziras
Director, Chief Business Officer
Director, Chief Business Officer
1.29M
--
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President
Executive Chairman of the Board, President
311.12K
-97.37%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
287.70K
+0.24%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月30日 週三
更新時間: 7月30日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Rands (Peter David)
72.07%
Nivorozhkin (Alex)
22.81%
Tang Capital Management, LLC
7.95%
Deep Track Capital LP
6.65%
Global X Investments Canada Inc.
5.82%
持股股東
持股股東
佔比
Rands (Peter David)
72.07%
Nivorozhkin (Alex)
22.81%
Tang Capital Management, LLC
7.95%
Deep Track Capital LP
6.65%
Global X Investments Canada Inc.
5.82%
股東類型
持股股東
佔比
Individual Investor
109.49%
Hedge Fund
28.45%
Investment Advisor
6.51%
Investment Advisor/Hedge Fund
6.43%
Private Equity
0.49%
Research Firm
0.47%
Bank and Trust
0.06%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
202
58.02M
152.31%
-77.17M
2025Q1
209
57.54M
286.29%
-78.15M
2024Q4
205
59.72M
283.54%
-81.34M
2024Q3
197
62.29M
285.74%
-324.75M
2024Q2
204
344.93M
166.65%
-48.46M
2024Q1
195
368.84M
163.99%
+249.67M
2023Q4
177
108.66M
110.45%
+25.70M
2023Q3
166
58.71M
23.51%
+14.44M
2023Q2
156
50.00M
26.24%
+942.60K
2023Q1
152
52.80M
27.84%
+4.58M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Rands (Peter David)
16.59M
76.78%
-3.01M
-15.34%
Nov 14, 2023
Nivorozhkin (Alex)
5.25M
24.3%
+280.74K
+5.65%
Mar 31, 2024
Tang Capital Management, LLC
1.83M
8.47%
+500.00K
+37.59%
Mar 31, 2025
Deep Track Capital LP
1.53M
7.08%
--
--
Mar 31, 2025
Global X Investments Canada Inc.
1.34M
6.2%
-213.08K
-13.73%
Feb 29, 2024
Point72 Asset Management, L.P.
1.33M
6.14%
+508.22K
+62.13%
May 20, 2025
Tziras (George)
1.29M
5.99%
--
--
Jul 24, 2024
Bartlone (Aaron Frank)
901.07K
4.17%
+200.00K
+28.53%
Jun 28, 2024
Rosalind Advisors, Inc.
810.92K
3.75%
--
--
Mar 31, 2025
Acorn Capital Advisors, LLC
734.39K
3.4%
+1.00
+0.00%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
AdvisorShares Psychedelics ETF
7.05%
iShares Biotechnology ETF
0.02%
Simplify Propel Opportunities ETF
0%
AdvisorShares Psychedelics ETF
佔比7.05%
iShares Biotechnology ETF
佔比0.02%
Simplify Propel Opportunities ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
公告日期
類型
比率
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
Aug 28, 2024
Merger
38<1
